Research for transfusion safety- priority of administration safety.
In Trasci recently various articles issued opinions where research for transfusion safety should be heading. A majority of them concentrated of production and standardization of the perfect and safe blood product in the future. However, the way the product is used by clinicians should be supported first to increase administration safety since the risks from inadequate administration exceeds the risk of product associated harm by far. Technical or computerized solutions have been tried in pilots but are far from marketability. Research efforts are needed to secure the clinical path of already very safe blood products.